Free Trial

Singular Genomics Systems (OMIC) Stock Price, News & Analysis

Singular Genomics Systems logo
$13.32
+0.32 (+2.46%)
(As of 10/31/2024 ET)

About Singular Genomics Systems Stock (NASDAQ:OMIC)

Key Stats

Today's Range
$12.55
$14.11
50-Day Range
$5.50
$16.79
52-Week Range
$5.34
$19.80
Volume
57,472 shs
Average Volume
34,027 shs
Market Capitalization
$33.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.75
Consensus Rating
Hold

Company Overview

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.

Singular Genomics Systems Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
33rd Percentile Overall Score

OMIC MarketRank™: 

Singular Genomics Systems scored higher than 33% of companies evaluated by MarketBeat, and ranked 846th out of 997 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Singular Genomics Systems has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Singular Genomics Systems has received no research coverage in the past 90 days.

  • Read more about Singular Genomics Systems' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Singular Genomics Systems is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Singular Genomics Systems is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Singular Genomics Systems has a P/B Ratio of 0.18. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Singular Genomics Systems' valuation and earnings.
  • Percentage of Shares Shorted

    5.93% of the float of Singular Genomics Systems has been sold short.
  • Short Interest Ratio / Days to Cover

    Singular Genomics Systems has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Singular Genomics Systems has recently decreased by 14.42%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Singular Genomics Systems does not currently pay a dividend.

  • Dividend Growth

    Singular Genomics Systems does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.93% of the float of Singular Genomics Systems has been sold short.
  • Short Interest Ratio / Days to Cover

    Singular Genomics Systems has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Singular Genomics Systems has recently decreased by 14.42%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Singular Genomics Systems has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Singular Genomics Systems this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Singular Genomics Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,166.00 in company stock.

  • Percentage Held by Insiders

    22.20% of the stock of Singular Genomics Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    65.80% of the stock of Singular Genomics Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Singular Genomics Systems' insider trading history.
Receive OMIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter.

OMIC Stock News Headlines

Urgent: This election is rigged
If you missed it, my emergency election broadcast is now available - but will be removed soon
See More Headlines

OMIC Stock Analysis - Frequently Asked Questions

Singular Genomics Systems' stock was trading at $13.8030 at the start of the year. Since then, OMIC shares have decreased by 2.3% and is now trading at $13.49.
View the best growth stocks for 2024 here
.

Singular Genomics Systems, Inc. (NASDAQ:OMIC) posted its earnings results on Tuesday, August, 13th. The company reported ($8.57) EPS for the quarter, topping the consensus estimate of ($8.86) by $0.29. The company had revenue of $0.74 million for the quarter, compared to analysts' expectations of $0.40 million. Singular Genomics Systems had a negative net margin of 3,375.72% and a negative trailing twelve-month return on equity of 54.66%.

Singular Genomics Systems shares reverse split on Wednesday, June 26th 2024. The 1-30 reverse split was announced on Wednesday, June 26th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Singular Genomics Systems (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. The company issued 8,500,000 shares at $20.00-$22.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO.

Shares of OMIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Singular Genomics Systems investors own include NVIDIA (NVDA), Tesla (TSLA), Albemarle (ALB), CrowdStrike (CRWD), Etsy (ETSY), Ford Motor (F) and Fluence Energy (FLNC).

Company Calendar

Last Earnings
8/13/2024
Today
10/31/2024
Next Earnings (Estimated)
11/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:OMIC
Fax
N/A
Employees
220
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.75
High Stock Price Target
$15.00
Low Stock Price Target
$6.50
Potential Upside/Downside
-21.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-94,820,000.00
Net Margins
-3,375.72%
Pretax Margin
-3,375.72%

Debt

Sales & Book Value

Annual Sales
$2.72 million
Book Value
$73.25 per share

Miscellaneous

Free Float
1,942,000
Market Cap
$34.02 million
Optionable
Optionable
Beta
1.49
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:OMIC) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners